|
Volumn 480, Issue 7377, 2011, Pages S40-S42
|
Drugs: More shots on target
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BORTEZOMIB;
CARFILZOMIB;
DEXAMETHASONE;
IMMUNOMODULATING AGENT;
LENALIDOMIDE;
MLN 9708;
POMALIDOMIDE;
PROTEASOME INHIBITOR;
THALIDOMIDE;
UNCLASSIFIED DRUG;
AMINO ACID;
CANCER;
CHEMOTHERAPY;
DRUG;
DRUG RESISTANCE;
ENZYME ACTIVITY;
HEMATOLOGY;
INHIBITOR;
PROTEIN;
RESEARCH WORK;
ARTICLE;
AUTOLOGOUS STEM CELL TRANSPLANTATION;
CANCER REGRESSION;
CYTOKINE PRODUCTION;
DRUG EFFICACY;
DRUG INDICATION;
FOOD AND DRUG ADMINISTRATION;
HEART DISEASE;
HUMAN;
IMMUNOMODULATION;
KIDNEY DISEASE;
LUNG DISEASE;
MULTIPLE MYELOMA;
MYELOMA CELL;
NAUSEA;
NEUROPATHY;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
ANTINEOPLASTIC AGENTS;
BORON COMPOUNDS;
BORONIC ACIDS;
CLINICAL TRIALS AS TOPIC;
DRUG RESISTANCE, NEOPLASM;
GLYCINE;
HUMANS;
IMMUNOLOGIC FACTORS;
MULTIPLE MYELOMA;
OLIGOPEPTIDES;
PROTEASE INHIBITORS;
PYRAZINES;
SURVIVAL RATE;
THALIDOMIDE;
THREONINE;
ARIZONA;
CALIFORNIA;
UNITED STATES;
|
EID: 83455203496
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/480S40a Document Type: Article |
Times cited : (14)
|
References (0)
|